Medical/Pharmaceuticals
China Pharmaceutical Holdings Co., Ltd. Launched A New Product
HAIKOU CITY, China, March 2, 2020 /PRNewswire/ -- China Pharmaceutical Holdings Limited (NYSE American: CPHI) ("China Pharma" or "Company"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that its subsidiary, Hainan ...
2020-03-02 20:00
6078
ConvaTec sharpens focus on Asia Pacific and emerging markets
SINGAPORE, March 2, 2020 /PRNewswire/ -- ConvaTec Group Plc is putting the Asia Pacific region, along with Latin America, The Middle East and Africa, at the forefront of its new operating model by establishing a fully integrated business unit called the Global Emerging Markets (GEM), according to...
2020-03-02 18:06
9894
Yuyu Pharma, Laying the foundation for establishing a global-level compliance system with one of Korea's top law firms
SEOUL, South Korea, March 2, 2020 /PRNewswire/ -- Yuyu Pharma (COO Robert Wonsang Yu, KRX 000220) announced today a review of its compliance policies and procedures with the support of the law firm, Kim & Chang. The Kim & Chang project team, consisting of 6 lawyers and 1 expert advisor, implement...
2020-03-02 17:00
1391
ERBITUX® Approved for First-line Use in China in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)
Approval is for ERBITUX® in combination with platinum-based therapy with fluorouracil for the first-line treatment of R/M SCCHN Pivotal Phase III study shows significant improvements with ERBITUX® in combination with platinum-based therapy with fluorouracil in response rate, disease progression ...
2020-03-02 15:02
5310
Sihuan Pharmaceutical Announces Clinical Research of Favipiravir, Co-Developed with the Academy of Military Medical Sciences of the People's Liberation Army, Has Commenced
HONG KONG, March 2, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that the clinical research of Favipiravir tablet, which was co-developed by the Group and t...
2020-03-02 14:15
7784
Luminex Corporation Submits VERIGENE(R) II Respiratory Flex Assay for FDA Clearance
AUSTIN, Texas, March 2, 2020 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that the company has submitted an application to the U.S. Food and Drug Administration (FDA) for 510(k) clearance of the VERIGENE® II RespiratoryFlex Assay, the second VERIGENE II assay to be submitted...
2020-03-02 10:00
6121
3SBIO makes investment in MPM's $100M Oncology Innovations Fund and donation to Dana-Farber cancer research
SHANGHAI, March 1, 2020 /PRNewswire/ -- MPM Capital (MPM) and Dana-Farber Cancer Institute have jointly announced onFebruary 26, 2020 the successful closing of the MPM Oncology Innovations Fund (INV) with$100M in capital, and the Dana-Farber Innovations Research Fund (IRF) with more than$26M in p...
2020-03-01 16:30
1578
Researchers Worldwide Are Using Berkeley Lights' Beacon Platform To Combat COVID-19
Berkeley Lights' proprietary technology, the Beacon® optofluidic platform, is currently used by researchers across three continents—the U.S.,China, and Australia—to help them find solutions for the Coronavirus EMERYVILLE, Calif., Feb. 29, 2020 /PRNewswire/ -- Berkeley Lights, Inc., a leader in c...
2020-02-29 01:00
3872
Wuhan's war on COVID-19: How China mobilizes the whole country to contain the virus
BEIJING, Feb. 28, 2020 /PRNewswire/ -- CGTN recently looked back on China's efforts to fight the ongoing new coronavirus outbreak in a recent report and released an original video. A health crisis struck China on the cusp of the new year. Wuhan, a metropolis of 11 million residents in central...
2020-02-28 20:18
4716
Ping An Launches COVID-19 Smart Image-Reading System to Help Control the Epidemic
HONG KONG and SHANGHAI, Feb. 28, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 02318; SSE: 601318) announced that the Corona Virus Disease 2019 (COVID-19) smart image-reading system was launched on 19 February. It wa...
2020-02-28 19:40
10550
LOTTE Vietnam Shopping Joint Stock Company donates medical masks for the Hospital for Tropical Diseases
HO CHI MINH CITY, Vietnam, Feb. 28, 2020 /PRNewswire/ -- LOTTE Vietnam Shopping Joint Stock Company donated 30,000 medical masks of Choice L brand to the Hospital for Tropical Diseases inHo Chi Minh City to help reverse the Covid-19 epidemic. Given the complicated situation of Covid-19, the dema...
2020-02-28 16:27
4222
JLK Inspection has announced signing of a partnership with the National TB Center (NTC) and the Clinton Health Access Initiatives (CHAI) in Lao PDR to conduct a tuberculosis screening project
SEOUL, South Korea, Feb. 28, 2020 /PRNewswire/ -- JLK Inspection Inc.
2020-02-28 14:51
1973
DERMALOG Fever Detection in Operation at Hanover Exhibition Grounds
The spread of coronavirus also affects the event industry. Congresses and trade fairs are postponed or even canceled worldwide for fear of a pandemic. Event organizer UKi Media & Events is using innovative technology from DERMALOG at its present trade fair inHanover to protect its visitors. HAMB...
2020-02-27 21:52
1904
Tessa Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to its CD30 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory CD30-positive Classical Hodgkin Lymphoma
SINGAPORE, Feb. 27, 2020 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced that the Company's investigational CD30-directed autologous chimeric antigen receptor T cell (CD30 CAR-T) therapy has been gran...
2020-02-27 20:00
2244
European Medicines Agency accepts submission of GSK's Marketing Authorisation Application for Zejula (niraparib) in first-line maintenance treatment for women with platinum-responsive advanced ovarian cancer
- Submission based on data from the Phase III PRIMA clinical study that demonstrated clinically meaningful outcomes of niraparib maintenance treatment in the first-line setting regardless of biomarker status LONDON, Feb. 27, 2020 /PRNewswire/ -- GlaxoSmithKline plc announced that the European M...
2020-02-27 17:00
1427
Samsung Biologics Confirms 'No Impact' of COVID-19 with Business Continuity Plan in Effect
SONGDO, South Korea, Feb. 24, 2020 /PRNewswire/ -- Samsung Biologics has been monitoring the COVID-19 situation closely since the initial outbreak in late January and taking proactive measures company-wide to ensure a safe working environment and continuous business operations. The company confi...
2020-02-27 15:49
1601
WuXi Diagnostics' integrated testing solution for COVID-19 epidemiological investigation and diagnosis
SHANGHAI, Feb. 27, 2020 /PRNewswire/ -- WuXi Diagnostics has successfully developed a series of COVID-19 detection products, including2019-nCoV IgM Detection kit (Enzyme-linked Immunoassay, ELISA), 2019-nCoV IgM/IgG Detection Kit (Enzyme-linked Immunoassay, ELISA) and 2019-nCoV Nucleic Acid Detec...
2020-02-27 15:47
1951
Country Garden Delivered 100,000 Protective Suits Directly from Sydney to Wuhan to Support Healthcare Workers
FOSHAN, China, Feb. 27, 2020 /PRNewswire/ -- On February 24, 2020, nearly 100,000 protective suits purchased by Country Garden Holdings (HK:2007) through the Guoqiang Foundation were delivered directly fromSydney, Australia to Wuhan via a chartered airplane. Along with supplies and equipment d...
2020-02-27 11:24
9435
Clinical Trial of Ganovo® and Ritonavir Combination Therapy on Novel Coronavirus Pneumonia
HANGZHOU and SHAOXING, China, Feb. 27, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today the advancement in Novel Coronavirus Pneumonia clinical trial of oral Ganovo® and Ritonavir combination therapy, led by Dr. Hongyi CHEN, the director of the Ninth Hospital ofNanchang...
2020-02-27 08:00
4080
New VITROS® XT 3400 Chemistry System from Ortho Clinical Diagnostics Enhances Its VITROS® XT Solutions, Offering Labs Faster, More Accurate Results and Trusted System Reliability to Ensure Better Patient Outcomes
RARITAN, N.J., Feb. 27, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the launch and availability of the VITROS® XT 3400 Chemistry System, which completes th...
2020-02-27 01:40
2252
Week's Top Stories
Most Reposted
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
[Picked up by 334 media titles]
2025-01-18 03:30
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
[Picked up by 307 media titles]
2025-01-18 17:00
HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
[Picked up by 304 media titles]
2025-01-20 14:27
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
[Picked up by 302 media titles]
2025-01-21 16:00
Infobip Research Unveils Opportunities for Brands to Engage Customers with Rich Communication Services (RCS) across APAC
[Picked up by 288 media titles]
2025-01-20 21:09
Most Read
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
2025-01-18 03:30
9917
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
2025-01-18 17:00
8954
Boosting Yeast Protein Production to Meet the Growing Global Demand for Alternative Proteins
2025-01-17 22:46
8916
Dongying's vibrant Spring Festival awaits visitors
2025-01-17 21:46
8753